Sanofi India Ltd SANOFI-IN:National Stock Exchange of India

*Data is delayed | Exchange | INR
Last | 3:23 PM IST
8,259.10quote price arrow down-229.10 (-2.70%)
Volume
13,179
52 week range
5,400.00 - 9,380.00
Loading...
  • Open8,475.00
  • Day High8,475.00
  • Day Low8,232.20
  • Prev Close8,488.20
  • 52 Week High9,380.00
  • 52 Week High Date02/23/24
  • 52 Week Low5,400.00
  • 52 Week Low Date05/02/23

Key Stats

  • Market Cap2,334.48M
  • Shares Out23.03M
  • 10 Day Average Volume18,946.3
  • Dividend167.00
  • Dividend Yield2.02%
  • Beta-
  • YTD % Change1.96

KEY STATS

  • Open8,475.00
  • Day High8,475.00
  • Day Low8,232.20
  • Prev Close8,488.20
  • 52 Week High9,380.00
  • 52 Week High Date02/23/24
  • 52 Week Low5,400.00
  • 52 Week Low Date05/02/23
  • Market Cap2,334.48M
  • Shares Out23.03M
  • 10 Day Average Volume18,946.3
  • Dividend167.00
  • Dividend Yield2.02%
  • Beta-
  • YTD % Change1.96

RATIOS/PROFITABILITY

  • EPS (TTM)261.78
  • P/E (TTM)31.55
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date05/03/2024
  • Div Amount117.00
  • Split Date-
  • Split Factor-

Latest On Sanofi India Ltd

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Sanofi India Limited is an India-based company, which is engaged in the business of manufacturing and trading of drugs and pharmaceuticals. The Company produces pharmaceutical formulations, dosage forms and offer a range of medicines across various therapeutic areas. Its product portfolio is focused on five therapeutic areas: diabetes, epilepsy, cardiology, allergy and pain care. In the diabetes area, the Company has an insulin portfolio under the brand name of Lantus, which...
Aditya Ditya
Non-Executive Independent Chairman of the Board
Rachid Ayari
Chief Financial Officer, Whole-time Director
Address
54/A
Sir Mathuradas Vasanji Road
Andheri East
Mumbai
400072
India